Levin Capital Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Levin Capital Strategies’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,610	Closed	-$201K	–	249
2022 Q2	$201K	Buy	+2,610	New	+$199K	0.02%	210
2021 Q2	–	Sell	-5,241	Closed	-$331K	–	377
2021 Q1	$331K	Hold	5,241	–	–	0.04%	192
2020 Q4	$325K	Hold	5,241	–	–	0.04%	202
2020 Q3	$316K	Buy	+5,241	New	+$315K	0.04%	187
2016 Q1	–	Sell	-27,080	Closed	-$1.86M	–	330
2015 Q4	$1.86M	Hold	27,080	–	–	0.03%	157
2015 Q3	$1.6M	Hold	27,080	–	–	0.03%	171
2015 Q2	$1.8M	Hold	27,080	–	–	0.03%	170
2015 Q1	$1.75M	Hold	27,080	–	–	0.03%	179
2014 Q4	$1.6M	Hold	27,080	–	–	0.02%	180
2014 Q3	$1.39M	Hold	27,080	–	–	0.02%	192
2014 Q2	$1.31M	Hold	27,080	–	–	0.02%	213
2014 Q1	$1.41M	Hold	27,080	–	–	0.02%	193
2013 Q4	$1.44M	Hold	27,080	–	–	0.02%	200
2013 Q3	$1.25M	Hold	27,080	–	–	0.02%	197
2013 Q2	$1.21M	Buy	+27,080	New	+$1.18M	0.02%	201

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Levin Capital Strategies's BMY Position: Q3 2022 in Review

Levin Capital Strategies sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 2,610 shares — an estimated $201K sold.

Levin Capital Strategies first reported a position in BMY in Q2 2013 and held it in 15 quarters. The position peaked at $1.86M in Q4 2015. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Levin Capital Strategies reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
Levin Capital Strategies sold 2,610 Bristol-Myers Squibb shares in Q3 2022, an estimated $201K.
Levin Capital Strategies first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 15 quarters.
Levin Capital Strategies's Bristol-Myers Squibb position peaked at $1.86M in Q4 2015.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Levin Capital Strategies's 13F filing for Q3 2022, filed 8 Nov 2022.